NBTX Nanobiotix
Company Analysis
Latest News
🔴 Nanobiotix is trading 7.4% down in pre-market with no clear company-specific announcement identified
Nanobiotix is trading 7.4% down now at $35.36 after no clear company-specific announcement was identified for September 9, 2026. - Broader sentiment is...
🔴 Nanobiotix is trading 5.1% down today despite broader market and biotech gains
Nanobiotix is trading 5.1% down at $39.54, with no fresh company-specific announcement or clearly disclosed catalyst for September 3, 2026 identified. -...
🟢 Nanobiotix is trading 10.23% up today as broader biotech-sector strength
Nanobiotix is trading $43.31, 10.23% up now, supported by broader biotech-sector strength. - The stock rebounded from its September 1, 2026 close of $39.29. -...
🟢 Nanobiotix is trading 6.77% up today with no clear company-specific catalyst identified
Nanobiotix is trading 6.77% up at $41.95, rebounding after closing at $39.29 on September 1, 2026; no clear company-specific catalyst has been identified for...
🔴 Nanobiotix is trading 5.3% down today after profit-taking amid biotech weakness
Nanobiotix is trading 5.3% down now at $42.75 after profit-taking following its recent gains. - No fresh company-specific announcement, earnings release, or...
🔴 Nanobiotix is trading 5.1% down in pre-market amid cited profit-taking
Nanobiotix is trading 5.1% down at $42.25 in a decline that appears technically driven, with profit-taking and negative momentum cited. - It closed at $44.50...
🟢 Nanobiotix is trading 6% up today as XBI ETF rises 2.06%
Nanobiotix is trading at $43.99, up 5.97%, primarily linked to biotech-sector strength, with the XBI ETF up 2.06%. - The move extends Nanobiotix’s rebound...
🟢 Nanobiotix is trading 5.47% up today as biotech ETF XBI gains 2.06%
Nanobiotix is trading at $41.83, up +5.47%, appearing primarily driven by biotech-sector strength. - No new company-specific announcement or analyst action...
🔴 Nanobiotix is trading 8.3% down today amid broader risk-off market pressure
Nanobiotix is trading 8.3% down at $39.95 amid broader risk-off pressure, with no fresh company-specific announcement or analyst action identified for August...
🔴 Nanobiotix is trading 5% down today as biotech stocks retreat after Moderna’s cancer-vaccine rally
Nanobiotix is trading lower at $43.06, down -5.13%, on August 20, 2026, as biotechnology shares give back gains following Moderna’s historic cancer-vaccine...
🟢 Nanobiotix is trading 5.9% up today on Moderna’s positive personalized cancer-vaccine Phase 3 results
Nanobiotix is trading 5.9% up now at $43.10 after biotech-sector strength lifted sentiment. - Biotech is rising 3.73%, supported by Moderna’s positive...
🟢 Nanobiotix is trading 7.5% up in after-hours trading with catalyst still unconfirmed
Nanobiotix is trading at $45.21, up 7.51%, with no confirmed catalyst identified. - Nanobiotix gained 9.76% during the August 17 regular session before...
🟢 Nanobiotix is trading 10.3% up today; catalyst remains unclear
Nanobiotix is trading 10.3% up at $42.26, but the catalyst remains unclear. - No clearly dated August 17, 2026 company-specific announcement, earnings...
🟢 Nanobiotix is trading 5% up
Nanobiotix is trading 5.1% up at $40.25, based on the provided live price context; no clear company-specific catalyst has been identified. - Searches found no...
🟢 Nanobiotix is trading 11% up today; no confirmed catalyst identified
Nanobiotix is trading 11% up at $40.16, after rising from the August 10 closing price of $36.18; no confirmed company-specific catalyst was identified for...
🟢 Nanobiotix is trading 8.5% up with no confirmed catalyst identified
Nanobiotix is trading 8.47% up now at $39.24 after opening-market gains on August 11, 2026; no confirmed company-specific catalyst was identified. - No fresh...
🟢 Nanobiotix is trading 10.56% up in pre-market with no confirmed catalyst
Nanobiotix is trading at $40.00, up 10.56%, with no confirmed company-news catalyst identified overnight. - No fresh earnings release, major filing, or...
🟢 Nanobiotix is trading 5.7% up in pre-market with no clear company-specific catalyst identified
Nanobiotix is trading $38.23 (+5.67%) up now, with no clear company-specific catalyst identified for August 11, 2026. - No fresh earnings release, major...
🔴 Nanobiotix is trading 5.5% down today — no clear company-specific catalyst identified
Nanobiotix is trading 5.5% down at $36.12 after no clear company-specific catalyst was identified for August 10, 2026. - The latest identifiable company...
🟢 Nanobiotix is trading 6.38% up in pre-market — catalyst remains uncertain
Nanobiotix is trading 6.38% up at $40.20 in pre-market, with no clear company-specific catalyst identified for August 7, 2026. - Its investor-relations page...